cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Sigilon Therapeutics Inc
3 own
5 watching
Current Price
$0.72
$-0.01
(-1.15%)
logo-sgtx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
23.21M
52-Week High
52-Week High
1.8967
52-Week Low
52-Week Low
0.29
Average Volume
Average Volume
0.03M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization23.21M
icon52-Week High1.8967
icon52-Week Low0.29
iconAverage Volume0.03M
iconDividend Yield--
iconP/E Ratio--
What does the Sigilon Therapeutics Inc do?
Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neurological manifestations of mucopolysaccharidosis type 1; SIG-007 to provide continuous and prolonged release of functional enzyme at levels sufficient to produce clinical benefits and alleviate progression of the downstream aspects of Fabry disease; and SIG-002 to replace islet cells for the treatment of type 1 diabetes. Sigilon Therapeutics, Inc. has a research collaboration and license agreement with Eli Lilly and Company for the development and commercialization of SLTx product candidates for the treatment of Type 1 Diabetes. The company was formerly known as Sigilon, Inc. and changed its name to Sigilon Therapeutics, Inc. in June 2017. Sigilon Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Sigilon Therapeutics Inc make?
News & Events about Sigilon Therapeutics Inc.
Zolmax
12days ago
Canaccord Genuity Group initiated coverage on shares of Sigilon Therapeutics (NASDAQ:SGTX Get Rating) in a research note released on Wednesday, Benzinga reports. The brokerage issued a buy rating and a $6.00 price target on the stock. Sigilon Therapeutics Price Performance NASDAQ:SGTX opened at $0....
Ticker Report
12days ago
Canaccord Genuity Group initiated coverage on shares of Sigilon Therapeutics (NASDAQ:SGTX Get Rating) in a research note released on Wednesday, Benzinga reports. The brokerage issued a buy rating and a $6.00 price target on the stock. Sigilon Therapeutics Price Performance NASDAQ:SGTX opened...
PR Newswire
9 months ago
Flagship Pioneering Expands Leadership Team with Appointment of Michael Severino as CEO-Partner Flagship Pioneering Expands Leadership Team with Appointment of Michael Severino as CEO-Partner PR Newswire CAMBRIDGE, Mass., April 13, 2022 CAMBRIDGE, Mass., April 13, 2022 /PRNewswire/ -- Flagship...
PR Newswire
11 months ago
Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies for 2022 Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies for 2022 Ranks #2 Most Innovative Company in North America PR Newswire CAMBRIDGE, Mass., March...
PR Newswire
11 months ago
Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs PR Newswire CAMBRIDGE, Mass., Feb. 28, 2022...
Frequently Asked Questions
Frequently Asked Questions
What is Sigilon Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Sigilon Therapeutics Inc shares?
plus_minus_icon
How can I buy Sigilon Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Sigilon Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Sigilon Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Sigilon Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Sigilon Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Sigilon Therapeutics Inc?
plus_minus_icon
What percentage is Sigilon Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Sigilon Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0.72
$-0.01
(-1.15%)
logo-sgtx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00